Pharmaceuticals Drug Recall: Q&A with Beth Riggio Last updated: May 9, 2024 4:43 pm By bexib 0 Min Read Share SHARE Beth Riggio, Vice President of Product Management, Global Products and Solutions at Cencora, discusses the challenges the industry faces with recalls and how to improve them. You Might Also Like APL and CurifyLabs Partner to Support Patients with 3D Printed Medical Technology Phase 2 PREDICT-ILD Imaging Study in Interstitial Lung Disease Begins New ways to determine drug value with health equity in mind Melissa Krebs Shares Gersana’s Vision for Innovative Wound Care Solutions Zongertinib demonstrates high objective response rates in previously treated advanced non-small cell lung cancer Share This Article Facebook Twitter Email Print Previous Article How AI improves keyword research Next Article What’s happening at Belgian ports should worry American automakers and policymakers Leave a comment Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Stay ConnectedFacebookLikeTwitterFollowYoutubeSubscribeTelegramFollowLatest News Valiram uses Atome to offer ‘buy now, pay later’ in Malaysia and Singapore Fintech Binance, Coinbase included among 16 crypto exchanges blocked in Cambodia Fintech Compton Arms Announces New Popular Kitchen Residency Hospitality & Tourism AI revolution will triple data center capacity in Southeast Asia by 2030 Fintech